Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the ...

GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...

The strategy and product exec said Tandem aims to give patients options and reach more people who haven’t yet used insulin ...

The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott's new head of diabetes business.

For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated ...

The oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 ...

As the markets for weight-loss drugs develop, pharma companies are having to adapt in search of the next big thing.

Abvance Therapeutics, a biotechnology company developing next-generation glucagon analogs and therapies to prevent ...

As diabetes rates soar in India, those over 40 face increased heart disease risks. Early intervention, healthy habits, and ...

At the diabetes conference, Eli Lilly presented results of a phase 1 trial of its experimental drug, eloralintide. Unlike GLP-1 drugs, it targets a hormone that slows stomach emptying. Over 12 weeks, ...

Robert F. Kennedy Jr. testified in front of largely combative congresspeople on vaccine policy, his MAHA report and more; the ...